Bird flu: Mexico prohibits poultry imports from Arkansas (Straits Times) MEXICO CITY - MEXICO is banning poultry imports from Arkansas because of a bird flu outbreak in the US state. The Agricultural Department says poultry meat, fertilized eggs, song birds and messenger pigeons are banned indefinitely. [News Source]

Mexico bans Arkansas poultry for now on bird flu (Reuters via Yahoo! News) Mexico will ban all imports of poultry and poultry products from Arkansas after a small flock in that U.S. state had been exposed to a mild form of bird flu, the agriculture ministry said on Wednesday. [News Source]

Mexico bans Arkansas poultry for now on bird flu (AlertNet) Source: Reuters MEXICO CITY, June 25 (Reuters) - Mexico will ban all imports of poultry and poultry products from Arkansas after a small flock in that U.S. state had been exposed to a mild form of bird flu, the ... [News Source]

Medicago’s H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal … (CCNMatthews via Yahoo! Finance) QUEBEC CITY, QUEBEC-- - Medicago Inc. today announced additional positive results for the Company's H5N1 Avian Influenza VLP vaccine from a preclinical immunogenicity study performed in ferrets, the most predictive animal model for evaluating the effectiveness of influenza vaccines in humans. [News Source]

Medicago’s H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal … (Marketwire via Yahoo! Finance) Medicago Inc. today announced additional positive results for the Company's H5N1 Avian Influenza VLP vaccine from a preclinical immunogenicity study performed in ferrets, the most predictive animal model for evaluating the effectiveness of influenza vaccines in humans. [News Source]

VGX Announces Publication of Preclinical Data for the Company´s Avian Flu Vaccine Candidate in PLoS ONE Journal (wallstreet:online AG) VGX Pharmaceuticals Inc. (VGX) announced today the publication in PLoS ONE - an international, peer-reviewed, [News Source]

VGX Announces Publication of Preclinical Data for the Company’s Avian Flu Vaccine Candidate in PLoS ONE Journal (Business Wire via Yahoo! Finance) BLUE BELL, Pa.----VGX Pharmaceuticals Inc. announced today the publication in PLoS ONE - an international, peer-reviewed, open-access, online publication - of preclinical data for the Company’s preventative DNA vaccine candidate for avian influenza, VGX-3400. [News Source]